Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Breast Cancer
100%
Primary Tumor
100%
Metastasis
100%
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
Axillary Nodes
100%
Metastatic Lesions
33%
Confirmatory Biopsy
33%
Breast Cancer Recurrence
33%
Immunohistochemistry
16%
Malignancy
16%
Therapeutic Target
16%
Adjuvant Therapy
16%
Fluorescence in Situ Hybridization
16%
Benign Condition
16%
Aberrations
16%
Systemic Treatment
16%
Biomarker Profile
16%
In Vivo Fluorescence
16%
Axillary Lymph Node Metastasis
16%
Chromogenic in Situ Hybridization
16%
Recurrent Breast Carcinoma
16%
Hybridization in Situ
16%
Tissue Collection
16%
Future Management
16%
Biomarker Discordance
16%
Medicine and Dentistry
Biopsy
100%
Metastatic Carcinoma
100%
Primary Tumor
100%
Breast Cancer
100%
Biological Marker
33%
Base
16%
Cancer
16%
in Situ Hybridization
16%
Immunohistochemistry
16%
Recurrent Disease
16%
Adjuvant Therapy
16%
Fluorescence in Situ Hybridization
16%
Breast Carcinoma
16%
Systemic Therapy
16%
Tissue Banking
16%